Clinical Trials Browser

INDUSTRY × Lymphoma, Extranodal NK-T-Cell × camrelizumab × Clear all

NCT03363555 2020-06-18

SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell